The OncLive Disparities in Cancer Care condition center page is a comprehensive resource for clinical news and expert insights on disparities in care with regards to race, gender, demographics, geographics, and socioeconomic status. This page features news articles, interviews in written and video format, and podcasts that focus on studies evaluating these various disparities and how they impact clinical trial enrollment and oncology treatment.
February 14th 2023
A renewed focus on dismantling the barriers and closing gaps in care will aid in the mission to drive down the rate of cancer mortality and incidence across disease states.
Stark Differences in Mortality Rates Emphasize Ongoing Racial Disparities in Breast CancerOctober 24th 2022
Bridget A. Oppong, MD, discussed the importance of recognizing and addressing gaps in outcomes between patients with breast cancer in different racial groups. She also addressed the need for better advocacy for Black patients and advocated for improved screening guidelines to close the gap in racial disparities in breast cancer care.
Black Patients With HCC, Those Living in High-Poverty Neighborhoods Have Higher Odds of Experiencing Treatment Delays
Data from a recent analysis revealed that nearly 1 in 7 patients with hepatocellular carcinoma experience treatment delays, with higher odds observed in Black patients and those living in high poverty neighborhoods.
Sylvester Names Dr. Sophia George to Lead the Cancer Center’s Focus on Diversity, Equity, and InclusionAugust 26th 2022
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has named Sophia George, PhD, the inaugural associate director of diversity, equity, and inclusion.
CCNE1 Amplifications Tied to Racial Disparities in Serous Endometrial Cancer OutcomesAugust 18th 2022
Julian Schink, MD, discusses a study evaluating racial differences in the mutational landscape of serous endometrial cancer, underscores the need for appropriate genomic testing and treatment for Black women with the disease, and explains the importance of racial representation across clinical trials.
Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research AwardsAugust 11th 2022
The National Cancer Institute-designated Montefiore Einstein Cancer Center has partnered with the Price Family Foundation to fund 8 research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.
Advances in Site Self-Assessment Tools Aim to Bolster Equity in Clinical Trials
National Cancer Institute-designated comprehensive cancer centers routinely perform clinical trial site self-assessments. However, participation in these types of assessments is far less commonplace among community oncology sites.
Retrospective Analysis Highlights Disparities in Germline Testing in Prostate CancerAugust 2nd 2022
Carrie Horton, MS, CGC, discusses how the findings from a retrospective analysis of germline testing rates among racially diverse groups of men with prostate cancer will guide future research and influence the steps community oncologists can take to increase testing rates.
ASCO, ACCC Issue Recommendations to Boost Clinical Trial DiversityJuly 24th 2022
The American Society of Clinical Oncology and the Association of Community Cancer Centers have issued a joint statement outlining 6 recommendations for boosting participation among underserved communities.
Survival is Significantly Poorer for Young Black Patients With AML Compared With White CounterpartsJuly 11th 2022
Despite receiving similar treatment, Black patients between the ages of 18 and 29 years with acute myeloid leukemia were twice as likely to die within 5 years compared with Whites.
Women in Oncology: How Leukemia Treatment has Changed and Stayed Stagnant Over the YearsJuly 8th 2022
Judith Karp, MD; Azra Raza, MD; and Michelle M. Le Beau, PhD, highlight the decades-long evolution of the leukemia field and express challenges such as defining the causes of leukemia and developing therapies to treat the disease and mitigate adverse effects like bone pain.
New USPSTF Guidelines Increase Lung Cancer Screening Among African AmericansJune 22nd 2022
The US Preventive Services Task Force updated its lung cancer screening guidelines in 2021 to include more members of vulnerable populations, including African Americans, women, and the LGBTQ community.
Black Patients Less Likely to Participate on Clinical Trials in Breast CancerMay 26th 2022
Black patients were less likely to be included in clinical trials that investigate newer treatments for metastatic breast cancer, despite having the highest death rate and shortest survival outcomes when compared with other racial and ethnic groups in the United States.
Addressing Barriers Contributing to Disparities in CRC Screening in Underserved PopulationsMay 20th 2022
Denalee O'Malley, PhD, sheds light on racial and ethnic disparities in colorectal cancer screening, and strategies that can be used to address existing barriers in the clinic and beyond.
Lower Rates of Negative Surgical Margins Found in Black Patients Vs White Patients with GI Tract CancerMay 10th 2022
Rates of negative surgical margins and adequate lymphadenectomies were lower in Black patients with gastrointestinal tract cancer compared with White patients, according to data from a retrospective cohort study published in JAMA Network Open.
Racial Disparities Revealed in Surgical Outcomes in Gastrointestinal Tract CancerMay 9th 2022
Sajid A. Khan MD, FACS, FSSO, discusses findings from the study on racial disparities in surgical outcomes and quality of care for GI tract cancer, plus what issues need to be addressed to close the gap in care.